Clinical registry of patients suffering from age-related macular degeneration (AMD) or diabetic macular oedema (DMO) who have been treated with anti-VEGF medications.
Multicentric system for the assessment of the progress and results of biological therapy of ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus.
Evaluation of efficacy of new spectroscopic biomarkers for the detection of early-stage pancreatic cancer.
Clinical registry of breast cancer patients who have been treated with trastuzumab (Herceptin®), lapatinib (Tyverb®), bevacizumab (Avastin®) and/or everolimus (Afinitor®).
International clinical registry of patients with chronic myeloid leukaemia.
Registry of patients suffering from severe persisting allergic asthma who have been treated with omalizumab (Xolair®).
System of informational support for the Cervical Cancer Screening Programme in the Czech Republic.
Clinical registry of neuromodulation techniques applied in patients suffering from chronic pain.
Non-interventional multicentre observational prospective database focusing on the collection and analysis of data on real mortality and morbidity in an unselected population of COPD patients.
Clinical registry of colorectal cancer (CRC) patients who have been treated with cetuximab (Erbitux®), bevacizumab (Avastin®) and/or panitumumab (Vectibix®).
Non-interventional multicentre retrospective and prospective longitudinal monitoring of patients with inflammatory bowel disease (IBD) who have been treated with biological therapies.
Clinical registry monitoring cases of bladder cancers treated with cystectomy and consecutive treatment.
The Czech National Haemophilia Programme (CNHP) is a non-interventional multicentre prospective study which monitors inherited haemorrhagic disorders: haemophilia, von Willebrand's disease and other haemorrhagic disorders.
Non-interventional, multicentre, retrospective and prospective study of patients with brain tumours, who have been treated in the Czech Republic according to the common clinical practice.
Detailed assessment of safety and efficacy of hybrid ablation of persistent and long-standing persistent atrial fibrillation using a combined (hybrid) approach – surgical thoracoscopic epicardial ablation and a subsequent complex cardiological endocardial ablation.
Multicentre research database for implementation of parametric monitoring of severe sepsis treatment directly in clinical practice.
Multicentre, national, observational, non-interventional, prospective study of paediatric patients with an acute infection of respiratory tract who have been treated with Erdomed.
Clinical registry of haemato-oncological patients in which antimycotic therapy has been administered.
Multicentre, non-interventional, retrospective and prospective monitoring of patients with chronic HCV infection who have been treated with direct-acting antiviral agents (DAAs) or with standard therapy.
A central registry dealing with the implantation of implantable cardioverter-defibrillators (ICD).
Registry of EGFR mutation testing results in patients with non-small-cell lung cancer (NSCLC) in the Czech Republic.
System of informational support for the Colorectal Cancer Screening Programme in the Czech Republic.
Central Czech registry of morphologically examined breast cancers, with particular emphasis on the collection of data regarding the examination of HER2/neu status in the Czech population.
System of informational support for the Breast Cancer Screening Programme in the Czech Republic.
Clinical registry of melanoma patients who have been treated with dabrafenib (Tafinlar®), ipilimumab (Yervoy®), nivolumab (Opdivo®), trametinib (Mekinist®), pembrolizumab (Keytruda®) and/or vemurafenib (Zelboraf®).
Registry collecting data on patients with myasthenia gravis, a rare autoimmune neuromuscular disorder
International clinical registry gathering data on the management of patients with non-small cell lung cancer (NSCLC) who were diagnosed at the clinical stage III.
Prospective observational multinational multicentre study aiming to cover all health care facilities providing anaesthesia in the peripartal period in the Czech Republic and Slovakia, thus getting the most accurate image possible about this segment of anaesthesiology.
Clinical registry of ovarian cancer patients who have been treated with bevacizumab (Avastin®) and/or olaparib (Lynparza®).
Parametric collection of basic clinical data on paediatric cancer patients, interactive analytical reports.
Clinical registry of pleural mesothelioma patients who have been treated with pemetrexed (Alimta®).
Non-interventional, multicentre, prospective study monitoring the development and treatment of congenital dysfunctions of the immune system.
Clinical registry of patients with chronic obstructive pulmonary disease (COPD) in Central and Eastern Europe.
Randomised trial comparing the effectiveness of ticagrelor and prasugrel in patients with ST segment elevation myocardial infarction (STEMI) who have been treated with primary PCI.
Registry of PAH (pulmonary arterial hypertension) patients who have been treated with parenteral prostanoids.
REaDY (REgistry of muscular DYstrophies) is a clinical registry of patients suffering from Duchenne/Becker's muscular dystrophy (DMD/BMD), spinal muscular atrophy (SMA), myotonic dystrophy (DM) or facioscapulohumeral muscular dystrophy (FSHD).
Registry of paediatric and adult patients with home-administered parenteral nutrition.
Clinical registry monitoring the epidemiology of gastrointestinal stromal tumours (GIST) as well as therapeutic approaches and treatment results in GIST patients in the Czech Republic and Slovakia.
Clinical registry of kidney cancer patients who have been treated with bevacizumab (Avastin®), everolimus (Afinitor®), pazopanib (Votrient®), sorafenib (Nexavar®), sunitinib (Sutent®) and/or temsirolimus (Torisel®).
Clinical registry focused on non-interventional monitoring of patients with pulmonary hypertension.
International clinical registry of patients with monoclonal gammopathies.
Registry of patients with first acute ischaemic stroke of the carotid circulation with permanent neurological deficit.
Clinical registry collecting data on patients who have undergone transcatheter aortic valve implantation (TAVI).
Registry of patients with essential thrombocythaemia or thrombocythaemia associated with another myeloproliferative disorder who have been treated with anagrelide (Thromboreductin®).
Clinical registry of non-small cell lung cancer (NSCLC) patients who have been treated with bevacizumab (Avastin®), erlotinib (Tarceva®), gefitinib (Iressa®), pemetrexed (Alimta®), afatinib (Giotrif®) and/or nintedanib (Vargatef®).